Holen Sie sich die Stockscreener-App
1.18
0.84%
-0.01
Vorhandelsmarkt:
1.18
Schlusskurs vom Vortag:
$1.19
Offen:
$1.2
24-Stunden-Volumen:
1.49M
Relative Volume:
1.23
Marktkapitalisierung:
$106.58M
Einnahmen:
$70.14M
Nettoeinkommen (Verlust:
$-76.24M
KGV:
-1.0631
EPS:
-1.11
Netto-Cashflow:
$-57.06M
1W Leistung:
-7.09%
1M Leistung:
-29.76%
6M Leistung:
-58.74%
1J Leistung:
-71.36%
1-Tages-Spanne:
$1.12
$1.22
1-Wochen-Bereich:
$1.12
$1.36
52-Wochen-Spanne:
$1.12
$4.46
Codexis Inc Stock (CDXS) Company Profile
Firmenname
Codexis Inc
Sektor
Branche
Telefon
650-421-8100
Adresse
200 PENOBSCOT DRIVE, REDWOOD CITY, CA
Compare CDXS vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CDXS
Codexis Inc
|
1.18 | 107.49M | 70.14M | -76.24M | -57.06M | -1.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Codexis Inc Stock (CDXS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-19 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-05-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-02-29 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2023-11-07 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2023-08-07 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2023-05-09 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2022-03-31 | Fortgesetzt | Piper Sandler | Overweight |
| 2022-03-02 | Fortgesetzt | Cowen | Outperform |
| 2021-04-12 | Eingeleitet | Piper Sandler | Overweight |
| 2021-03-01 | Eingeleitet | Stifel | Buy |
| 2021-02-26 | Bestätigt | H.C. Wainwright | Buy |
| 2020-03-10 | Eingeleitet | The Benchmark Company | Buy |
| 2019-01-17 | Hochstufung | First Analysis Sec | Neutral → Outperform |
| 2018-05-16 | Eingeleitet | Stephens | Overweight |
| 2017-10-13 | Bestätigt | H.C. Wainwright | Buy |
| 2017-05-31 | Eingeleitet | Jefferies | Buy |
| 2017-01-26 | Herabstufung | First Analysis Sec | Overweight → Equal-Weight |
| 2017-01-04 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2016-01-06 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Codexis Inc Aktie (CDXS) Neueste Nachrichten
Positive Sentiment Still Eludes Codexis, Inc. (NASDAQ:CDXS) Following 29% Share Price Slump - simplywall.st
Macro Review: Does Codexis Inc offer margin of safetyGlobal Markets & Precise Buy Zone Identification - baoquankhu1.vn
Does Codexis Inc. stock trade at a discount to peersWeekly Investment Summary & Free Growth Oriented Trading Recommendations - mfd.ru
Codexis (CDXS) Achieves ISO 9001:2015 Certification - GuruFocus
Codexis Inc. Achieves ISO 9001:2015 Certification for Quality Management Excellence - Quiver Quantitative
Codexis Achieves ISO 9001:2015 Certification - GlobeNewswire
Analysts Expect Breakeven For Codexis, Inc. (NASDAQ:CDXS) Before Long - Yahoo Finance
RSI Check: What makes Codexis Inc stock attractive todayQuarterly Trade Report & Technical Confirmation Trade Alerts - baoquankhu1.vn
Enzyme Engineering Market to Get an Explosive Growth | Novozymes - openPR.com
Biofuel Enzymes Market Set to Soar: Innovations Driving - openPR.com
Aberdeen Group plc Expands Stake in Codexis Inc with Significant Share Acquisition - GuruFocus
MACD Signal: Will Codexis Inc benefit from rising consumer demandMarket Performance Recap & Daily Price Action Insights - baoquankhu1.vn
Moving Averages: What are Codexis Incs recent SEC filings showingQuarterly Trade Summary & Growth Oriented Trade Recommendations - baoquankhu1.vn
Aug PreEarnings: What is DYCQRs book value per shareWeekly Investment Report & AI Forecast for Swing Trade Picks - baoquankhu1.vn
Dividend Watch: Is Codexis Inc. stock vulnerable to regulatory risks2025 Sector Review & Daily Momentum Trading Reports - Bộ Nội Vụ
Codexis and Axolabs Partner to Advance Enzymatic RNA Manufacturing - Contract Pharma
How Codexis Inc. stock reacts to Fed rate cutsShare Buyback & Smart Swing Trading Alerts - ulpravda.ru
Codexis CSO Stefan Lutz sells $7949 in shares By Investing.com - Investing.com UK
Codexis CSO Stefan Lutz sells $7949 in shares - Investing.com
Is Codexis Inc. stock safe for conservative investorsJuly 2025 Short Interest & Safe Entry Momentum Tips - Улправда
Codexis (CDXS) Partners with Axolabs for Innovative RNA Manufact - GuruFocus
New partnership tests greener way to mass-produce RNA medicines - Stock Titan
Codexis Expands Reach of the ECO Synthesis® Manufacturing Platform through a Signed Evaluation Agreement with Axolabs for Oligonucleotide Therapeutics - Yahoo Finance
Q3 2025 Codexis Inc Earnings Call Transcript - GuruFocus
Enzyme Engineering Market Set for Rapid Growth and Trend - openPR.com
Codexis strengthens board with biotech veteran Arthur Levin - MSN
Will Codexis Inc. stock benefit from green energy trendsJuly 2025 Levels & Free Weekly Watchlist of Top Performers - DonanımHaber
Opaleye Management Inc. Reduces Stake in Codexis Inc. - GuruFocus
How Codexis Inc. stock reacts to job market dataPortfolio Profit Report & Expert-Curated Trade Recommendations - Улправда
Opaleye management sells Codexis (CDXS) shares worth $877,846 By Investing.com - Investing.com Nigeria
Opaleye management sells Codexis (CDXS) shares for $1.87 million By Investing.com - Investing.com South Africa
Opaleye management sells Codexis (CDXS) shares for $1.87 million - Investing.com
Codexis : Amendment to Statement of Changes in Beneficial Ownership (Form 4/A) - marketscreener.com
MACD Signal: Why Codexis Inc stock could see breakout soonJuly 2025 Trade Ideas & AI Enhanced Trading Alerts - moha.gov.vn
Specialty Enzymes Market size to cross $12.2 Billion by 2035 | - openPR.com
Perhaps timely catching Codexis Inc (CDXS) would be a good idea - Setenews
Is Codexis Inc. stock supported by strong fundamentalsTrade Risk Report & Verified Technical Signals - Newser
Will Codexis Inc. stock benefit from upcoming earnings reportsMarket Risk Summary & Entry Point Confirmation Alerts - Newser
Codexis' ECO Synthesis® Manufacturing Platform: Transforming RNA Therapeutics - CBS News
Enzyme Engineering Market is Going to Boom: Strategic Insights - openPR.com
A Look at Codexis Inc (CDXS) Shares in the Recent Past Indicates Growth - setenews.com
Major Shareholder Sells Off a Chunk of Codexis Stock! - TipRanks
Codexis (CDXS) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Operating cash flow per share of Codexis, Inc. – DUS:4QK - TradingView
Owner Opaleye Management Inc Sells 514,341 ($877.8K) Of Codexis Inc [CDXS] - TradingView
[Form 4] CODEXIS, INC. Insider Trading Activity - Stock Titan
Check out these key findings about Codexis Inc (CDXS) - setenews.com
Codexis Inc (CDXS) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Telemark Asset Management LLC Increases Stock Position in Codexis, Inc. $CDXS - MarketBeat
Dir Wolf Files To Sell 8,952 Of Codexis Inc [CDXS] - TradingView
Finanzdaten der Codexis Inc-Aktie (CDXS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.24%
0.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):